Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

J. Bubeník

• Genetically Modified Vaccines Augment the Efficacy of Cancer Surgery and Chemotherapy

  J. Bubeník

  2009, Vol. 55, Issue 6, pp. 199-200
• Immunotherapeutic Efficacy of Vaccines Generated by Fusion of Dendritic Cells and HPV16-Associated Tumour Cells

  Jana Šímová, J. Bubeník, J. Bieblová, M. Indrová, T. Jandlová

  2005, Vol. 51, Issue 1, pp. 19-24
• The Role of NK1.1⁺ Cells in the Protection against MHC Class I⁺ HPV16-Associated Tumours

  Jana Šímová, J. Bubeník, J. Bieblová, T. Jandlová

  2004, Vol. 50, Issue 6, pp. 200-202
• Immunogenicity of Dendritic Cell-Based HPV16 E6/E7 Peptide Vaccines: CTL Activation and Protective Effects

  Marie Indrová, M. Reiniš, J. Bubeník, T. Jandlová, J. Bieblová, V. Vonka, J. Velek

  2004, Vol. 50, Issue 6, pp. 184-193
• MHC Class I⁺ and Class I^- HPV16-Associated Tumours Expressing the E7 Oncoprotein Do Not Cross-react in Immunization/Challenge Experiments

  Jana Šímová, R. Mikyšková, V. Vonka, J. Bieblová, J. Bubeník, T. Jandlová

  2003, Vol. 49, Issue 6, pp. 230-234
• Adjuvant Cytokine Treatment of Minimal Residual Disease after Surgical Therapy in Mice Carrying HPV16-Associated Tumours: Cytolytic Activity of Spleen Cells from Tumour Regressors

  Marie Indrová, R. Mikyšková, T. Jandlová, V. Vonka, J. Bubeník, J. Bieblová

  2003, Vol. 49, Issue 6, pp. 217-222
• Immunotherapy of HPV 16-Associated Tumours with Tumour Cell Line/Dendritic Cell Line (TC-1/DC2.4) Hybrid Vaccines

  Jana Šímová, J. Bieblová, T. Jandlová, J. Bubeník

  2003, Vol. 49, Issue 5, pp. 203-206

The following name might also represent this author:

Jan Bubeník

• Interleukin 12 in Cancer Treatment

  Jan Bubeník

  2011, Vol. 57, Issue 1, pp. 1-2
• Gene Therapy of Cancer by Vaccines Carrying Inserted Immunostimulatory Genes

  Jan Bubeník

  2007, Vol. 53, Issue 3, pp. 71-73
• Depletion of T_reg Cells Augments the Therapeutic Effect of Cancer Vaccines

  Jan Bubeník

  2006, Vol. 52, Issue 6, pp. 202-204
• Human Papillomavirus (HPV) and HPV-Associated Tumour Vaccines

  Jan Bubeník

  2006, Vol. 52, Issue 1-2, pp. 45-46
• MHC Class I Downregulation, Tumour Escape from Immune Surveillance and Design of Therapeutic Strategies

  Jan Bubeník

  2005, Vol. 51, Issue 1, pp. 1-2
• Interleukin-2 Therapy of Cancer

  Jan Bubeník

  2004, Vol. 50, Issue 3-4, pp. 120-130
• Dedication to Professor Jan Svoboda, Ph.D., D.Sc.

  Jan Bubeník

  2004, Vol. 50, Issue 3-4, pp. 77-77
• Prospects for Immunotherapy of MHC Class I-Deficient Tumours

  Jan Bubeník

  2003, Vol. 49, Issue 3, pp. 95-99